School of Medicine
Research equipment in a lab

Collaborations with industry

We work with small businesses and global companies to deliver innovative pharmaceutical solutions, medical technologies, and patient-centred interventions. 

Our Expertise and Facilities

The School of Medicine has a strong connection with industry underpinned by our expertise and links with the NIHR Nottingham Biomedical Research Centre, Precision Imaging Beacon, and Nottingham Clinical Trials Unit.

We support the development and testing of innovative new treatments through the Nottingham Clinical Research Facility with specific expertise in experimental medicine and early phase clinical trials and in collaboration with our NHS partners. Our expertise in informatics underpins the management and utilisation of data across all our research. 

We provide skills and facilities to support innovation that tackles health challenges.

Clinical Research Facility

Our Facilities

Researchers at the School of Medicine

Our Researchers

Colllaboration with industry - Cochlear 320x320px

Case study: Collaboration between University of Nottingham and Cochlear 

Cochlear Limited is a global leader in implantable hearing solutions, helping people to hear and be heard, and connecting with others to live a full life. The collaboration between Cochlear and University of Nottingham is a multi-year clinical study to address a wider patient population with severe hearing loss that could benefit from cochlear implant technology. Professor Doug Hartley is the chief investigator of the study from the University of Nottingham.

Find out more UoN and Cochlear clinical trial


Colllaboration with industry - Astrazeneca 320x320px

Case study: Collaboration between University of Nottingham and AstraZeneca

AstraZeneca is working with University of Nottingham's Professor Gordon Moran, Professor of Gastroenterology at the School of Medicine, to explore underlying mechanisms of inflammatory bowel diseases such as Crohn's Disease and Ulcerative Colitis. The collaboration activities include a multi-year, multi-centre study that will look at the effect of different treatments on patients’ outcomes to help predict treatment response.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.


Spin-out companies 320x320px

Spin-out companies in healthcare

Our collaborations have led to pharmaceutical and technological breakthroughs with a number of spin-out companies being formed by researchers from the School of Medicine.

We provide support to spin-out companies that have the potential to create impact, tackle health challenges and make a difference to the world around us. 

Discover our spin-out companies


Collaborate with us 320x320px

Collaborate with us 

We can work with you to:

  • Find facilities and expertise to help you achieve your research goals
  • Develop a collaborative research proposal for funding
  • Place a researcher into your business to help you deliver a research project

Contact us to express interest in collaboration


School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Call 0115 748 4098 ext.30031 or please see our 'contact us' page for further details